Atai Life Sciences Statistics

Total Valuation

FRA:9VC has a market cap or net worth of EUR 424.84 million. The enterprise value is 364.24 million.

Market Cap	424.84M
Enterprise Value	364.24M

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	200.75M
Shares Outstanding	n/a
Shares Change (YoY)	+3.07%
Shares Change (QoQ)	+9.68%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	111.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	246.48
PB Ratio	3.02
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.64
EV / Sales	222.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.00

Financial Position

The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.19.

Current Ratio	4.07
Quick Ratio	3.50
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.37
Interest Coverage	-29.03

Financial Efficiency

Return on equity (ROE) is -79.43% and return on invested capital (ROIC) is -28.31%.

Return on Equity (ROE)	-79.43%
Return on Assets (ROA)	-26.04%
Return on Invested Capital (ROIC)	-28.31%
Return on Capital Employed (ROCE)	-57.90%
Revenue Per Employee	31,919
Profits Per Employee	-2.55M
Employee Count	54
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.50%
50-Day Moving Average	1.46
200-Day Moving Average	1.38
Relative Strength Index (RSI)	67.49
Average Volume (20 Days)	1,776

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.50

Income Statement

In the last 12 months, FRA:9VC had revenue of EUR 1.72 million and -137.84 million in losses. Loss per share was -0.84.

Revenue	1.72M
Gross Profit	2.09M
Operating Income	-89.61M
Pretax Income	-138.48M
Net Income	-137.84M
EBITDA	-89.05M
EBIT	-89.61M
Loss Per Share	-0.84

Full Income Statement

Balance Sheet

The company has 90.86 million in cash and 26.80 million in debt, giving a net cash position of 64.06 million.

Cash & Cash Equivalents	90.86M
Total Debt	26.80M
Net Cash	64.06M
Net Cash Per Share	n/a
Equity (Book Value)	140.88M
Book Value Per Share	0.70
Working Capital	80.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -71.89 million and capital expenditures -947,405, giving a free cash flow of -72.84 million.

Operating Cash Flow	-71.89M
Capital Expenditures	-947,405
Free Cash Flow	-72.84M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	121.04%
Operating Margin	-5,198.98%
Pretax Margin	-8,034.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:9VC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.07%
Shareholder Yield	-3.07%
Earnings Yield	-32.45%
FCF Yield	-17.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:9VC has an Altman Z-Score of -2.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.66
Piotroski F-Score	n/a